| Disclosure of detailed information about remuneration of key management |
| | | | | | | | | | | For the three months ended | | For the six months ended | | | June 30, | | June 30, | (in EUR 000) | | 2026 | | 2025 | | 2026 | | 2025 | Short-term remuneration & compensation (1) | | 635 | | 751 | | 1,140 | | 1,425 | Post-employment benefits | | 21 | | 14 | | 39 | | 35 | Share based payment (2) | | 687 | | 229 | | 904 | | 554 | Total | | 1,343 | | 994 | | 2,083 | | 2,014 |
(1) | Includes base remuneration, fringe benefits, short term (one-year) performance related bonus (i.e. variable remuneration), sign-on bonuses. |
(2) | Warrant expense under IFRS 2. |
|
| Disclosure of detailed information about transactions with related parties |
| | | | | | | | | | | For the six months ended | | For the six months ended | | | June 30, 2026 | | June 30, 2025 | | | Set up of | | Board | | Set up of | | Board | (in EUR 000) | | Production Line | | Remuneration | | Production line | | Remuneration | Cochlear | | — | | — | | 52 | | — | Robelga SRL | | — | | 70 | | — | | 59 | Kevin Rakin | | — | | 47 | | — | | 32 | Pierre Gianello | | — | | 27 | | — | | 27 | Jurgen Hambrecht | | — | | 32 | | — | | 32 | Rita Mills | | — | | 40 | | — | | 39 | Giny Kirby | | — | | 29 | | — | | 25 | Wildman Ventures LLC | | — | | 40 | | — | | 38 | Total | | — | | 285 | | 52 | | 252 | Amounts outstanding at period-end | | — | | 111 | | — | | 110 |
| | | | | | | | | | | For the three months ended | | For the three months ended | | | June 30, 2026 | | June 30, 2025 | | | Set up of | | Board | | Set up of | | Board | (in EUR 000) | | Production Line | | Remuneration | | Production line | | Remuneration | Cochlear | | — | | — | | — | | — | Robelga SRL | | — | | 47 | | — | | 31 | Kevin Rakin | | — | | 25 | | — | | 16 | Pierre Gianello | | — | | 13 | | — | | 13 | Jurgen Hambrecht | | — | | 16 | | — | | 16 | Rita Mills | | — | | 19 | | — | | 19 | Giny Kirby | | — | | 14 | | — | | 13 | Wildman Ventures LLC | | — | | 16 | | — | | 14 | Total | | — | | 150 | | — | | 122 | Amounts outstanding at period-end | | — | | 111 | | — | | 110 |
|